.

Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma

LAUR Repository

Show simple item record

dc.contributor.author Mansour, Ahmad M.
dc.contributor.author Arvelo, Fernando
dc.contributor.author Al Kahtani, Eman
dc.contributor.author Zegarra, Hernando
dc.contributor.author Abboud, Emad
dc.contributor.author Anand, Rajiv
dc.contributor.author Ahmadieh, Hamid
dc.contributor.author Sisk, Robert A.
dc.contributor.author Ghazi, Nicola G.
dc.date.accessioned 2019-06-19T09:17:00Z
dc.date.available 2019-06-19T09:17:00Z
dc.date.copyright 2014 en_US
dc.identifier.issn 2090-0058 en_US
dc.identifier.uri http://hdl.handle.net/10725/10862
dc.description.abstract We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 12 months, and 5.5 at 24 months. CNV was subfoveal in 14 eyes, juxtafoveal in 5, extrafoveal in 5, and peripapillary in 2. By paired comparison, mean decrease from baseline was 119.7 microns at 6 months (n = 15; P = 0.001 ), 105.3 microns at 1 year (n = 10; P = 0.03 ), and 157.6 microns at 2 years (n = 7;p = 0.08 ). BCVA improved by 3.3 lines at 6 months after therapy (n = 26; P = 0.003 ), 2.8 lines (n = 20; p less than 0.001 ) at 1 year, and 3.1 lines ( n = 20; P = 0.01) at 2 years. We conclude that intravitreal anti-VEGF injections improve vision in majority of eyes with CNV from choroidal osteoma. en_US
dc.language.iso en en_US
dc.title Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma en_US
dc.type Article en_US
dc.description.version Published en_US
dc.author.school SOM en_US
dc.author.idnumber 201000154 en_US
dc.author.department N/A en_US
dc.description.embargo N/A en_US
dc.relation.journal Journal of Ophthalmology en_US
dc.journal.volume 2014 en_US
dc.identifier.doi http://dx.doi.org/10.1155/2014/210458 en_US
dc.identifier.ctation Mansour, A. M., Arevalo, J. F., Al Kahtani, E., Zegarra, H., Abboud, E., Anand, R., ... & Navea Tejerina, A. (2014). Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma. Journal of ophthalmology, 2014. en_US
dc.author.email nicola.ghazi@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://www.hindawi.com/journals/joph/2014/210458/abs/ en_US
dc.author.affiliation Lebanese American University en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR


Advanced Search

Browse

My Account